Table of Content




1. Executive Summary


2. Global Lyme Disease Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Lyme Disease Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Lyme Disease Diagnostic Market by Diagnostic Test
3.3.1: Serological Test
3.3.2: Nucleic Acid Amplification Techniques
3.3.3: Urine Antigen Tests
3.3.4: Lymphocytic Transformation Test
3.3.5: Immunofluorescent Staining
3.3.6: PCR Analysis
3.3.7: Others


3.4: Global Lyme Disease Diagnostic Market by Technology
3.4.1: Molecular Diagnostics
3.4.2: Brain MRI
3.4.3: Spinal Tap
3.4.4: Echocardiogram
3.4.5: Electrocardiogram
3.4.6: Monoclonal Antibodies
3.4.7: Flow Cytometry
3.4.8: Gel Microdroplets
3.4.9: Others

3.5: Global Lyme Disease Diagnostic Market by End Use
3.5.1: Hospitals & Clinics
3.5.2: Pathology labs
3.5.3: Pharmaceutical Industries
3.5.4: Clinical Research Institute
3.5.5: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Lyme Disease Diagnostic Market by Region
4.2: North American Lyme Disease Diagnostic Market
4.2.1: North American Lyme Disease Diagnostic Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
4.2.2: North American Lyme Disease Diagnostic Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others

4.3: European Lyme Disease Diagnostic Market
4.3.1: European Lyme Disease Diagnostic Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
4.3.2: European Lyme Disease Diagnostic Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others

4.4: APAC Lyme Disease Diagnostic Market
4.4.1: APAC Lyme Disease Diagnostic Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
4.4.2: APAC Lyme Disease Diagnostic Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others

4.5: ROW Lyme Disease Diagnostic Market
4.5.1: ROW Lyme Disease Diagnostic Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
4.5.2: ROW Lyme Disease Diagnostic Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Diagnostic Test
6.1.2: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Technology
6.1.3: Growth Opportunities for the Global Lyme Disease Diagnostic Market by End Use
6.1.4: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Region

6.2: Emerging Trends in the Global Lyme Disease Diagnostic Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Lyme Disease Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Lyme Disease Diagnostic Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Abbott Laboratories
7.2: Qiagen
7.3: Biosystems
7.4: Bio-Rad Laboratories
7.5: Immunetics
7.6: Roche Diagnostics
7.7: T2 Biosystems
7.8: Graphene Frontiers
7.9: Alere
7.10: Boulder Diagnostics